|
Facebook Changes Ad Policies for Clinical Trials
(Thursday, January 6, 2022) Facebook will stop offering a few popular tools for targeted advertising of clinical trials to potential participants soon. The tools together called “Detailed Targeting” allows presenting targeted advertisements to patients based on health conditions. These changes may affect trials that depend primarily on social media for finding patients such as cancer studies, neurological disorders and indication related to causes such as diabetes awareness, lung cancer awareness or chemotherapy. According to the announcement from Facebook, this is primarily to protect patient privacy and exploitation of personal information available on Facebook such as one supporting a cause or discussing a disease. Social media is still a relatively small domain for clinical trial recruitment with less than 5% trials using social media campaigns for recruitment and less than 1% depending solely on social media for recruiting. Most trial recruitments are still led by physicians talking to their patients and health centers such as hospitals and clinics posting information to their visitors. So, the impact of this Facebook policy will be limited at the time. However, If you are planning to run or are already running a patient recruitment campaign on Facebook, you need to now these new rule that will be in effect on 19th Jan. 
AUTHOR
Dr. Mukesh Kumar Founder & CEO, FDAMap Email: mkumar@fdamap.com Linkedin: Mukesh Kumar, PhD, RAC Instagram: mukeshkumarrac Twitter: @FDA_MAP Youtube: MukeshKumarFDAMap |
|
|
|
